Search - tctmd.com

Displaying 1 - 20 of 79

Sort: Relevancy | Date

News Daily News

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

L.A. McKeown

February 06, 2026

News Daily News

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

Caitlin E. Cox

February 02, 2026

News Daily News

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Michael O'Riordan

January 30, 2026

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

Michael O'Riordan

December 18, 2025

News Daily News

AI-Supported Coaching Shows Promise for Improving Glycemic Control

L.A. McKeown

August 25, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza

Todd Neale

July 25, 2025

News Daily News

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

L.A. McKeown

July 24, 2025

News Daily News

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

Michael O'Riordan

April 25, 2025

News Daily News

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Caitlin E. Cox

February 26, 2025

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Daily News

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Michael O'Riordan

January 13, 2025

News Daily News

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

L.A. McKeown

December 05, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Daily News

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Michael O'Riordan

September 24, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Daily News

ACC/AHA Clarify How Social Determinants of Health Impact CVD

Caitlin E. Cox

August 28, 2024

News Daily News

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Michael O'Riordan

August 19, 2024

Advertisement

Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis

Nearly 150 Million US Adults Eligible for CKM Syndrome Meds

Even With Optimized GDMT, HFrEF Prognosis Remains Dire

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide

AI-Supported Coaching Shows Promise for Improving Glycemic Control

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Cardiac Biomarkers Equally Apt to Rise in COVID-19, Influenza

Key Subgroups of HF Patients Missing Out on SGLT2 Inhibitors: Registry Data

Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds

GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Change in Kidney Function With Finerenone Doesn’t Impact Treatment’s Benefit

Rethinking the Evidence for ICDs for HFrEF in Light of Today’s GDMT

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Little Pre- and Postmarket Testing for Most Recalled CV Devices

ACC/AHA Clarify How Social Determinants of Health Impact CVD

Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content